What is Nonalcoholic Steatohepatitis?
Nonalcoholic Steatohepatitis (NASH) is a type of fatty liver disease in which the cells of your liver store too much fat and become inflamed. If left untreated, NASH can lead to severe liver cell damage, and fibrosis (buildup of scar tissue) of the liver. NASH could possibly lead to cirrhosis or liver cancer.
Nonalcoholic Steatohepatitis Clinical Trials
We have many different studies of Nonalcoholic Steatohepatitis (NASH) that are conducting trials on patients with known diagnoses of NASH, and have not found their current treatment to be effective, or are willing to contribute to research of NASH. Patients who qualify for our NASH clinical trials may receive compensation for their time, see a board-certified physician at no cost to them, and have access to possible investigational medications.
What is the purpose of a clinical trial?
The purpose of conducting clinical trials for NASH is to determine the most effective and safe treatment options, and how those might apply differently to different individuals. Clinical trials are the method of translating research into new medicines and treatments that can provide new and improved patient outcomes. The lengthiest step in conducting clinical trials is often finding participants for the trials. The outcomes of clinical trials are one of the vital considerations of the U.S. Food and Drug Administration’s drug approval process. Without FDA approval, there could be no advances in patient therapeutics.
How Do I Get Involved?
If you have Nonalcoholic Steatohepatitis (NASH) and want to get involved in a clinical trial for NASH, you should fill out the form at the top of this page, and you may be matched to a clinical trial that is right for you.